✦ LIBER ✦

Drug levels, anti-drug antibodies, and clinical efficacy of the anti-TNFα biologics in rheumatic diseases

✍ Scribed by C. C. Mok, D. van der Kleij, G. J. Wolbink

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity, the elephant in the room

✍ Pixley, John 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 59 KB

Letter: measurement of anti-TNF-α levels

✍ Chaparro, M.; Gisbert, J. P. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Should anti-TNF-α drug levels and/or ant

✍ Denis Mulleman; Emilie Ducourau; Gilles Paintaud; David Ternant; Hervé Watier; P 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 287 KB

Quantitative Comparison of the Neutraliz

✍ Buurman, Dorien J. ;Pham, B.T. ;Blokzijl, Tjasso ;Faber, Klaas Nico ;van der Log 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Use of biological disease-modifying anti

✍ L. K. King; A. Lee; A. Anandacoomarasamy 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

P481 Impact of serum drug level and huma

✍ Jauregui-Amezaga, A.; Ordas, I.; Gallego, M.; Ramirez, A.; Pino, S.; Masamunt, M 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 116 KB